Letter to the editorThe role of ERCC2 polymorphisms in breast cancer risk
Section snippets
Acknowledgments
We wish to thank Luísa Manso Oliveira, Lylliane Luz, and Maria do Carmo Alves for technical assistance. The projects from Fundação Calouste Gulbenkian (69405) and Fundação da Ciência e Tecnologia (FCT) (POCTI/BIO/38922/2000 and POCTI/QUI/57110/2004) support our current research. The PhD grants SFRH/BD/2931/2000 and SFRH/BD/17828/2004 from FCT are also acknowledged.
References (14)
- et al.
Single nucleotide polymorphisms for DNA repair genes in breast cancer patients
Clin Chim Acta
(2005) - et al.
XPD exon 10 and 23 polymorphisms and DNA repair in human skin in situ
Carcinogenesis
(2001) - et al.
ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population
Cancer Epidemiol Biomarkers Prev
(2004) - et al.
Common polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not associated with breast cancer risk
Cancer Epidemiol Biomarkers Prev
(2005) - et al.
Obesity and genetic polymorphism of ERCC2 and ERCC4 as modifiers of risk of breast cancer
Exp Mol Med
(2005) - et al.
Association of polymorphisms in ERCC2 gene with non-familial thyroid cancer risk
Cancer Epidemiol Biomarkers Prev
(2005) - et al.
The absence of death by breast cancer among indigenous women living in Mato Grosso, Brazil 2000: protection or undernotification?
J Womens Cancer
(2002)
There are more references available in the full text version of this article.
Cited by (3)
Associations between XPD polymorphisms and risk of breast cancer: A meta-analysis
2010, Breast Cancer Research and Treatment
Copyright © 2006 Elsevier Inc. All rights reserved.